This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Andrew Nicholls: Innovator in Pharmaceutical Compositions
Introduction
Andrew Nicholls is a notable inventor in the field of pharmaceuticals, particularly recognized for his work on orally administered combinations of beta-lactam antibiotics and avibactam derivatives for treating bacterial infections. His innovative approach aims to enhance the effectiveness of antibiotic treatments against bacteria that produce beta-lactamase enzymes.
Latest Patents
Andrew Nicholls holds a patent for "Orally Administered Combinations Of Beta Lactam Antibiotics And Avibactam Derivatives For Treating Bacterial Infections." This patent describes pharmaceutical compositions that include a beta-lactam antibiotic, such as ceftibuten, and an avibactam derivative. The compositions are designed for oral administration, providing a therapeutically effective amount of both components in the systemic circulation of a patient.
Career Highlights
Andrew Nicholls is currently associated with Arixa Pharmaceuticals, Inc., where he contributes to the development of innovative pharmaceutical solutions. His work focuses on creating effective treatments for bacterial infections, which is a significant concern in modern medicine.
Collaborations
Some of his notable coworkers include Joaquim Trias and Carole Sable, who collaborate with him in advancing pharmaceutical research and development.
Conclusion
Andrew Nicholls is a key figure in the pharmaceutical industry, with a focus on developing effective treatments for bacterial infections. His contributions are vital in the ongoing battle against antibiotic resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile